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P rimary spinal column tumors are rare with more than 90% being metastases of solid tumors. 1 Chondrosarcomas are the second most common primary malignant spine tumor after Ewing sarcoma. 1 Chondrosarcomas may develop de novo or by malignant transformation of a benign chondral lesion. 2 Within the vertebra, chondrosarcomas not only develop primarily in the posterior elements with extension into the vertebral body (45%) but may also be confined to the posterior elements (40%) or vertebral body (15%). 3 Radiographic appearance depends on the tumor grade. Computed tomographic (CT) imaging demonstrates bony destruction with ''mineralization of the chondroid matrix'' and commonly soft tissue involvement. 3 In the absence of an associated tissue mass, a clear lytic lesion with sclerotic borders may be observed. 3, 4 Magnetic resonance imaging (MRI) demonstrates a high T2 signal as a result of the high water content of hyaline cartilage. 3 Surgical resection is the mainstay of therapy, as chondrosarcomas tend to be resistant to chemotherapy and radiotherapy. 5 Historically, the Enneking classification was developed for the surgical staging of primary bone tumors in the appendicular skeleton, based on histological behavior, anatomic extent, and presence of distant metastases. The Enneking classification divides malignant tumors into three stages, with subdivisions A and B (Table 1) . 6, 7 Stage III denotes metastatic disease and, generally, incurable tumors. On the basis of the tumor stage, Enneking also recommends a surgical margin.
The application of the Enneking system in the treatment of primary bone tumors has led to a longer patient life expectancy, [8] [9] [10] yet its application in the spine has not been widely accepted. The complex anatomy of the spine imposes additional challenges, such as the involvement of the epidural compartment, tumor-related spinal instability, and the involvement of nerve roots. Subsequently, the treatment of primary spine tumors has followed general orthopedic and neurosurgical spine principles rather than oncology principles. 11 To address these challenges, Weinstein, Boriani, and Biagini developed a system (WBB classification) for the surgical staging of primary spine tumors. 12 A reliability study of the Enneking and WBB classifications showed moderate interobserver and near perfect intraobserver reliability for both classifications for staging and treatment guidance. 13 The validity of both classifications is yet to be determined.
The low incidence of primary spine tumors proposes difficulties for conducting high-quality spinal oncology research, resulting in current literature mainly consisting of case reports and limited case series. This lack of research has led to heterogeneous treatment strategies for spine tumors mainly based on the experience of the spine surgeon.
The purpose of this study is to determine whether the application of the Enneking classification in the management of spinal chondrosarcomas influences local recurrence and survival.
MATERIALS AND METHODS

Design
An international, multicenter, retrospective review of prospectively collected data or ambispective design with crosssectional follow-up was conducted.
14 Each of the 11 participating centers was granted ethics approval. Patients included in the study had a diagnosis of a spinal chondrosarcoma, underwent surgical intervention between June 1987 and October 2011, and received regular surgical follow-up in one of the participating spine centers. Patients were excluded if they were admitted for treatment of a metastatic spinal tumor, diagnosed with a primary spinal cord tumor, or the recorded follow-up was less than six months postoperative.
Demographic, tumor histology, final pathology resection margins, Enneking classification, local recurrence, and survival data were collected from clinical charts and institutional databases. Whenever necessary, governmental databases were accessed to retrieve data concerning survival. Data were captured in a secure web-based application (REDCap; Vanderbilt University, Nashville, TN).
Patients were divided into two cohorts: Enneking appropriate (EA) and Enneking inappropriate (EI). They were categorized as EA when the final pathological assessment of the margin matched the Enneking recommendation, and otherwise, they were categorized as EI. Generally for chondrosarcoma, Enneking recommends wide or marginal margins. If this was achieved, then the surgery was described as EA, and if not, then it was EI. Those patients who underwent a previous surgical intervention for their chondrosarcoma and their resection was described as intralesional were also considered EI in their definitive surgery.
Surgical Technique
A range of surgeon preferences, differences in tumor location, size, and aggressiveness lead to a variety of surgical techniques. Some centers strictly followed Enneking principles while others did not. Sometimes, proximity of critical anatomy and extent of tumor prevented recommended margins.
Adjuvant chemotherapy and radiation therapy have been administered as salvage therapies, predominantly in patients after incomplete resection or in the palliative phase at the discretion of the treating physician.
Pathology Results
The final declaration of EA or EI resection margins was based on the pathology results of the surgical specimen, performed by an experienced musculoskeletal pathologist. The Enneking classification distinguishes between wide and marginal resections. However, due to the complex anatomy of the spine, these two categories were combined, as sparing of the dura in a marginal resection is generally preferred over a wide resection including the dura as a margin. The grade of the tumor was also determined by an experienced musculoskeletal pathologist, although the 
Statistical Analysis
Data were described using descriptive statistics (mean/ standard deviation or median/range for continuous variables; absolute number/frequency distribution for categorical variables). For differences between cohorts, the Chi-squared test was used for categorical variables, and Student t-test or Wilcoxon-Mann-Whitney test, as appropriate, for continuous variables. Univariate analysis, using Kaplan-Meier survival curves and log-rank tests, was performed over a 10-year period postoperative to identify factors that influenced local recurrence and survival. Subsequently, to further investigate local recurrence and survival, multivariate Cox proportional hazard modeling was used. Due to multi-collinearity, some variables, although significant at the univariate analysis, were not included in the model. Risk ratio (RR) was used to estimate the association between local recurrence and survival. The significance level was set at P 0.05. All statistical analyses were performed using STATA (version 12.0, College Station, TX).
RESULTS
A total of 111 patients with chondrosarcoma were identified. Patient baseline characteristics are summarized in Table 2 . There were 74 (67%) males and 37 (33%) females with a mean age of 47 years (range ¼ 16-84 yrs) at surgery. Pain was reported as a symptom in 98 (92%) patients. Twenty-nine (26%) patients had a previous spine tumor operation at a different center before they were referred to one of the participating spine centers, and 20 of 29 (69%) were reported with intralesional resections, thus considered EI procedures. A histological diagnosis by CT-trocar biopsy was made in 46 (54%) patients. There were 72 (65%) tumors that occurred in the mobile spine and 39 (35%) in the fixed spine. Data about Enneking appropriateness were available for 104 patients: 60 (58%) received an EA procedure and 44 (42%) received an EI procedure. Adjuvant therapy was given in 35 (32%) patients: 18 who received an EI procedure, 13 who received an EA procedure, and four whose procedure type was unknown. The median patient follow-up was 3.1 years (range ¼ 203 d-18.7 yrs). The mean tumor size was 6.7 cm (range ¼ 0.4-39 cm) from anterior-posterior, 5.9 cm (range ¼ 0.4-28 cm) from left-right, and 5.9 cm (range ¼ 1-26 cm) from cephaladcaudad. In Table 3 , the chondrosarcoma characteristics are summarized. Clinical characteristics for each Enneking appropriate cohort are outlined in Table 4 . Statistically significant differences between cohorts were found for the vertebral level of the tumor (P ¼ 0.019), whether the patient received adjuvant therapy (P ¼ 0.034), and local recurrence (P ¼ 0.005).
Local Recurrence
Thirty-seven (35%) patients suffered a local recurrence; 12 of 56 (21%) patients in the EA group and 21 of 44 (48%) in the EI group (Table 5) . Kaplan-Meier analysis demonstrated a significant difference between the EA and EI group for time to first local recurrence (P ¼ 0.010; Figure 1 ). An intralesional excision margin was significantly associated with an increased rate of local recurrence (P < 0.001; Table 5 ). Contrarily, the absence of adjuvant therapy was significantly associated with a lower rate of local recurrence (P ¼ 0.004). Upon univariate analysis, vertebral level, number of vertebrae affected, tumor volume, and tumor grade were not significantly associated with local recurrence (Table 5) . Upon multivariate analysis, there was borderline evidence that an EI procedure was associated with a high risk of local recurrence compared with those who received an EA procedure [P ¼ 0.052, hazard ratio (HR) ¼ 2.09, 95% 
Survival
Thirty-six (32%) patients died during the study period. Considering only those patients for whom we have data available for Enneking appropriateness, 15 of 60 (25%) EA patients and 17 of 44 (39%) EI patients died (Table 4) . Kaplan-Meier analysis demonstrated no difference between the EA and EI group for survival (P ¼ 0.529; Table 5 ). In the univariate analysis, the involvement of one or two vertebral levels (P ¼ 0.040) and the absence of adjuvant therapy (P ¼ 0.002) were significantly associated with improved overall survival, while for low-grade tumors, the evidence was of borderline significance (P ¼ 0.051) ( Table 5 ). Vertebral level, tumor volume, and type of surgical margin were not significantly associated with survival. Multivariate analysis showed three factors to be associated with poor overall survival: increasing age at surgery (P ¼ 0.009, HR ¼ 1.16, 95% CI: 1.04-1.29), involvement of three or more vertebral levels (P ¼ 0.008, HR ¼ 2.58, 95% CI: 1.28-5.19), and adjuvant therapy (P ¼ 0.007, HR ¼ 2.79, 95% CI: 1.32-5.89) ( Table 6 ). Tumor grade was not associated with survival. Local recurrence was strongly associated with death, with an RR of 3.6 (P ¼ 0.010). Adjusting for Enneking appropriateness did not significantly alter the result.
DISCUSSION
Primary bone tumors are rare, with an even lower incidence in the spinal column. Due to their low incidence, highquality research leading to evidence-based treatment regimens is lacking. The Enneking classification was historically developed for the staging and management of primary bone tumors of appendicular skeleton tumors resulting in improved survival rates. Its implementation in the treatment of primary spine tumors has not been widely accepted. We present the largest cohort of solely spinal chondrosarcomas using the Enneking classification for surgical staging and treatment guidance.
Our study demonstrated an almost significant association (P ¼ 0.052) between a procedure with EI surgical margins and an increased rate of local recurrence; this is in agreement with several other studies. 4 ,15,15 -20 Boriani et al. 4 retrospectively reviewed 22 mobile spine chondrosarcoma cases and demonstrated a 100% recurrence rate in patients treated with intralesional excision; 80% of these patients died of disease. Three out of 14 patients treated with en bloc resection showed local recurrence, yet two of these patients had histologically proven contaminated margins. Similarly, Yang et al. 15 reported a 100% recurrence rate for intracapsular piecemeal resection and no recurrence in patients treated with en bloc resection. Strike and McCarthy 16 analyzed 16 spinal chondrosarcoma patients: two patients underwent subtotal resection and both died of their disease; 14 patients underwent en bloc resection, where five developed a recurrence and eventually died of their disease. An international multicenter cohort study by Boriani et al. 17 on the treatment of chondrosarcoma (94 patients) reported a local recurrence rate of 49.1% after intralesional resection, significantly less compared with the previous reported local recurrence rates. Yet, with an odds ratio (OR) of 12.20, a significant association between local recurrence and intralesional surgical margins was still found. 17 Regarding overall and tumor-free survival, our study showed a strong relationship between local recurrence and overall survival rates. Hsieh et al. 21 studied the longterm outcomes after en bloc resection for 20 cases of chondrosarcoma and chordoma. They found a 91.7% tumor-free survival after en bloc resection with clear margins, with a mean disease-free interval of 51 months. In contrast, 66.7% of patients with contaminated margins or intralesional excision suffered a recurrence, with a mean disease-free interval of only 17 months. In addition, Boriani et al.
17 demonstrated a strong relationship between local recurrence and chondrosarcoma-related death (OR ¼ 18.41). Recently, Yin et al. 20 reported on prognostic factors for patients with spinal chondrosarcomas. Twentyfour of 98 patients suffered a distant metastasis, with the lung being the most common site. A strong relationship between distant metastases and overall survival was reported (HR ¼ 16.33).
Molecular targeted therapy is gaining popularity in the treatment of cancer. It interferes with abnormal signaling pathways in tumor cells and forms the basis for personalized cancer medicine. Liang et al. 22 studied the expression of the Aurora Kinase family in chondrosarcoma. The Aurora Kinase family (Aurora Kinase A, B, and C) is involved in normal cell cycle regulation and is highly expressed in different types of malignant tumors. 22 A significant correlation between the expression of Aurora Kinase A and B and the grade of malignancy, tumor invasiveness, and recurrence rate of chondrosarcoma was found. 22 Furthermore, Aurora Kinase A expression was significantly correlated with a poor prognosis. 22 In addition, Jin et al. 23 studied the expression of RUNX3, a tumor suppressor gene, in chondrosarcoma. Increased expression of RUNX3 correlated with a favorable prognosis, whereas decreased expression correlated with a poor prognosis. The expression of RUNX3 and Aurora Kinase A and B may be used in the future as prognostic markers and may form the basis of new nonsurgical treatment options.
Although this study represents the largest cohort of spinal chondrosarcomas, limitations exist. Firstly, the study design was ambispective, resulting in incomplete information for some variables. Secondly, a median follow-up of 3.1 years was short. Increasing the followup time would provide additional insight into the tumor behavior's local recurrence and survival patterns. Lastly, due to the large time span, complex anatomy, and multicenter approach, variability among treatment strategies exists. This, however, strengthens generalizability, something not found in previously published case series. Treatment strategies have changed within the last two decades due to imaging, implant, and surgical technique advancements. Tumors previously thought to be unresectable with EA margins are now resectable. Although this is a limitation for analyzing specific surgical techniques, it does not impact the primary research question, as the study focuses on EA versus EI margins, not how they were achieved. If effective adjuvant treatments had been developed, historical biases would be an issue, but as chondrosarcoma remains a surgical disease, the bias is minimal. Furthermore, with the involvement of multiple international centers, there are now sufficient numbers to allow for a true cohort design. Conventional radiation therapy and chemotherapy have been used as treatment modalities after incomplete resection of chondrosarcomas to theoretically increase local tumor control. 4, 18, 24 The exception would be mesenchymal chondrosarcomas which are rare, but treated with chemotherapy; however, detailed histology regarding chondrosarcoma subtypes was unknown in this study and this is a limitation. Historically, chondrosarcomas tend to be resistant to adjuvant therapy with most studies reporting little benefit. 4, 18, 24 An explanation might be that both chemotherapy and radiotherapy affect mostly fast dividing cells. Chondrosarcomas are slow growing tumors with a low fraction of dividing cells. 25 In addition, chondrosarcomas are poorly vascularized and have a rich extracellular matrix, which impairs the penetration of chemotherapy. 25 Treatment with proton beam radiotherapy has been reported to be effective in incomplete resected chondrosarcomas. 25, 26 The systematic review of Boriani et al. 27 reported a local control rate of 90% after subtotal resection. In our study, considering only those patients for whom we have data available for Enneking appropriateness, 18 (41%) patients received adjuvant therapy following EI resection compared with 13 (22%) patients who received adjuvant therapy after EA resection. Univariate analysis showed an association between lower local recurrence rates, improved survival rates, and the absence of adjuvant therapy. This may be explained by a bias in treatment selection. Taking into consideration the known relationship between decreased survival rates and contaminated resection margins, patients with contaminated resection margins were likely biased to receive adjuvant therapy in order to maximize their treatment regimen. This is in agreement with the study of Yin et al., 20 which demonstrated that patients who underwent adjuvant intraoperative chemotherapy or adjuvant radiotherapy had an increased risk for local recurrence.
Total en bloc resection with EA margins is the proposed treatment regimen for chondrosarcomas due to their high rate of recurrence after incomplete resection. However, the complex anatomy of the spine with the close relation to vasculature, the spinal cord, and other neurological structures makes an en bloc resection with wide surgical margins a challenge for the spine surgeon and often requires multidisciplinary care. In addition, the incidence of adverse events after en bloc resection is high even when these surgical procedures are performed at experienced spine centers. 2 However, en bloc resection with disease-free margins should be performed if recommended by surgical staging systems, taking the decreased local recurrence rate with clear resection margins into consideration.
The lack of standardized treatment algorithms limits high-quality research, but moreover preoperative planning and communication between surgeons. 28 Despite the low incidence and treatment challenges proposed by primary spine tumors, it appears that they should be managed and studied in the future using the Enneking and WBB classifications. This will improve the treatment of these rare tumors, and in turn, guarantee uniform reporting of results and enhance research quality.
Key Points
Enneking-inappropriate surgical management increases the risk of local recurrence. Furthermore, local recurrence is strongly associated with chondrosarcoma-related death (risk ratio of 3.6, P ¼ 0.010). Surgeons should aim for Enneking-appropriate resection with disease-free margins for spinal chondrosarcomas when technically feasible. Despite the low incidence of spinal chondrosarcomas, they should be managed and studied according to the Enneking and Weinstein-Boriani-Biagini classifications in order to improve the treatment and quality of future research. 
